Flagship Biosciences, Inc retweeted
Have you registered yet to join us next Tuesday, June 22nd at 11 AM MDT for a live webcast on tissue-based (biomarker) IVDs/CDx development insights? Register now! bit.ly/3vqh4CXX
#Webinar #CDx #ImageAnalysis
Flagship Biosciences, Inc retweeted
Our members @FlagshipBio and @pfizer recently worked together to validate computational analysis for detection & reproducible scoring of a #PTK7 #IHC assay with Flagship's cTA® platform. The results: bit.ly/2UuoxSQ
Flagship Biosciences, Inc retweeted
Replying to @SEQSTER
@seqster @TeselaGen @daptics_ai @iSpecimen @Ximedica @FlagshipBio @QorvoInc @benchling @Parsortix @EY_Parthenon
Plenary Session Panel happening at #TRICON: Emerging #Technologies and Industry Perspectives
Flagship Biosciences, Inc retweeted
Wednesday Plenary Keynote Panel on Emerging Technologies and Industry Updates. #TRICON - thank you to our panelists from: @seqster @TeselaGen @iSpecimen @Ximedica @daptics_ai @QorvoInc @FlagshipBio @benchling @Parsortix
Flagship Biosciences, Inc retweeted
.@FlagshipBio is recognized for its industry-leading AI-powered cTA platform for predictive diagnostics, earning it the 2018 Global Technology Innovation Award. prnewswire.com/news-releases…
Flagship Biosciences, Inc retweeted
NEW WHITEPAPER: Using Artificial Intelligence To Determine Patient Response To #Immunotherapy - Download Today! bit.ly/2KSMqyP #AI #diagnostics #biology #technology
Flagship Biosciences, Inc retweeted
#SITC2017 Scientific Highlights
Day 1 Report - blog.sitcancer.org/2017/11/s…
Day 2 Report - blog.sitcancer.org/2017/11/s…
Flagship Biosciences, Inc retweeted
Summit Highlights Utrophin Modulation as a Potential Universal Treatment Option in DMD at Action Duchenne : inpublic.globenewswire.com/r…
Flagship Biosciences, Inc retweeted
From cancer vaccines to CAR T cell therapy, immunotherapy is transforming cancer treatment. Learn more: ow.ly/5Ypd30fXAye
Flagship Biosciences, Inc retweeted
Dr. Curran @MDAndersonNews : strategies to "warm" tumors. #SITC2017
Flagship Biosciences, Inc retweeted
Mayo Clinic #pathologists have discovered a new tissue biomarker, DNAJB9, for fibrillary glomerulonephritis. mayocl.in/2x9RV1b
Flagship Biosciences, Inc retweeted
#JITC Review: The immune system in cancer metastasis: friend or foe? ow.ly/Qb2Y30fVWJZ
Flagship Biosciences, Inc retweeted
$NVS announces offer to acquire $AAAP, to expand company’s oncology portfolio and access new technology platform bit.ly/2yVFRVo
Flagship Biosciences, Inc retweeted
New Partnership for Accelerating Cancer Therapies (#PACT) aims to facilitate continued progress in #immunotherapy: nih.gov/news-events/news-rel…
Flagship Biosciences, Inc retweeted
News: NIH partners with 11 leading biopharmaceutical companies to accelerate the development of new… dlvr.it/Pv5Pv8 #NIH #NIHnews
Flagship Biosciences, Inc retweeted
#JITC Review: The immune system in cancer metastasis: friend or foe? ow.ly/Qb2Y30fVWJZ
Flagship Biosciences, Inc retweeted
Late-Breaking Abstract titles for #SITC2017 are now online! Titles for oral and poster presentations available: sitcancer.org/2017/abstracts…
Flagship Biosciences, Inc retweeted
We are presenting new data this week at #LiverMtg17 on investigational compounds for #NASH. @AASLDTweets
Flagship Biosciences, Inc retweeted
Cancer researcher Christina Trout of @Celgene discusses the future of immuno-oncology. Read & listen at: bit.ly/2g1KOkf #GoBoldly
Flagship Biosciences, Inc retweeted
Retweet to raise awareness about #metastaticbc.































